Drug-interaction-induced rhabdomyolysis

Nephrology Dialysis Transplantation

Volumn 11, Issue 9, 1996, Pages 1846-1847

  Segaert, M F ^a   De Soete, C ^a   Vandewiele, I ^a   Verbanck, J ^a  

^a Heilig Hart Ziekenhuis   (Belgium)

Author keywords

Cyclosporin A; Itraconazole; Rhabdomyolysis; Simvastatin

Indexed keywords

ALLOPURINOL; CLONIDINE; CYCLOSPORIN A; DIGITOXIN; ENALAPRIL; GLIQUIDONE; ITRACONAZOLE; METHYLPREDNISOLONE; SIMVASTATIN;

AGED; ARTICLE; CASE REPORT; DRUG DEGRADATION; DRUG METABOLISM; HUMAN; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MALAISE; MALE; MUSCLE WEAKNESS; MYCOSIS; PRIORITY JOURNAL; RHABDOMYOLYSIS;

EID: 0029798220     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027682     Document Type: Article

References (5)

1. Arellano F, Krupp P. Muscular disorders associated with cyclosporin. Lancet 1991; 337: 915
2. Deslypere JP, Vermeulen A. Rhabdomyolysis and simvastatin. Ann Intern Med 1991; 114: 342
3. Arnadottir M, Eriksson LO, Thysell H, Karkas JD. Plasma concentration profiles of simvastatin. 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitory activity in kidney transplant recipients with and without cyclosporin. Nephron 1993; 65:410-413
4. Kramer MR, Marshall SE, Denning DW et al. Cyclosporine and itraconazole interaction in heart and lung transplant recipients. Ann Intern Med 1990; 113: 327-329
5. Lees RS, Lees AM. Rhabdomyolysis from the coadministration of lovastatin and the antifungal drug itraconazole. N Engl J Med 1995; 333: 664